Table 3 Associations between miliary and PFS.

From: Analysis of non-small cell lung cancer with miliary lung metastasis in patients harboring epidermal growth factor receptor mutations

 

cHR (95% CI)

p value

aHR (95% CI)

p value

Age (ref =  < 65)

0.94 (0.68, 1.29)

0.687

0.80 (0.56, 1.14)

0.209

Gender (ref = female)

0.94 (0.68, 1.29)

0.685

0.80 (0.52, 1.22)

0.296

Smoking (ref = no)

1.12 (0.77, 1.64)

0.556

1.18 (0.70, 1.97)

0.535

PS (ECOG) (ref = 0–1)

2.30 (1.66, 3.20)

 < 0.001*

2.33 (1.61, 3.37)

 < 0.001*

Bone metastasis (ref = no)

1.27 (0.94, 1.72)

0.126

0.97 (0.68, 1.38)

0.869

Brain metastasis (ref = no)

1.47 (1.06, 2.04)

0.020*

1.41 (0.99, 2.02)

0.058

Liver metastasis (ref = no)

1.96 (1.29, 2.99)

0.002*

2.22 (1.40, 3.53)

0.001*

EGFR (ref = 19 deletion)

1.34 (0.98, 1.82)

0.064

1.25 (0.90, 1.75)

0.187

TKI (ref = 1st generation)

0.68 (0.49, 0.93)

0.015*

0.59 (0.42, 0.83)

0.003*

Miliary (ref = no)

1.47 (1.05, 2.05)

0.025*

1.11 (0.75, 1.63)

0.612